{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:42:06Z","timestamp":1791916926564,"version":"4.3.4"},"reference-count":71,"publisher":"National Academy of Sciences","issue":"2","license":[{"start":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T00:00:00Z","timestamp":1514246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000910","name":"Conrad N. Hilton Foundation","doi-asserted-by":"publisher","award":["20150232"],"award-info":[{"award-number":["20150232"]}],"id":[{"id":"10.13039\/100000910","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006955","name":"Office of Extramural Research, National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS096748"],"award-info":[{"award-number":["R01NS096748"]}],"id":[{"id":"10.13039\/100006955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001017","name":"California Community Foundation","doi-asserted-by":"publisher","award":["BAPP-15-118094"],"award-info":[{"award-number":["BAPP-15-118094"]}],"id":[{"id":"10.13039\/100001017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2018,1,9]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Molecular mechanisms underlying distinct disabilities during neurological diseases may differ based on the neurological pathway involved. Multiple sclerosis (MS) is multifocal, characterized by distinct disabilities affecting walking, vision, cognition, and fatigue. Neuroprotective treatments tailored for each disability may be more effective than nonspecific treatments aiming to reduce a composite of disabilities in clinical trials. Here, we use the MS model to apply a cell-specific and region-specific gene expression approach to discover targets in distinct neuroanatomic regions. Altered cholesterol synthesis gene expression in astrocytes in spinal cord and optic nerve was identified as a potential target for walking and visual disabilities, respectively. This disability-specific discovery approach represents a strategy for finding neuroprotective treatments for multifocal neurodegenerative diseases.<\/jats:p>","DOI":"10.1073\/pnas.1716032115","type":"journal-article","created":{"date-parts":[[2017,12,26]],"date-time":"2017-12-26T12:40:43Z","timestamp":1514292043000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":245,"title":["Cell-specific and region-specific transcriptomics in the multiple sclerosis model: Focus on astrocytes"],"prefix":"10.1073","volume":"115","author":[{"given":"Noriko","family":"Itoh","sequence":"first","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Tassoni","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Ren","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Kaito","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ao","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, University of California, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vista","family":"Farkhondeh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadley","family":"Johnsonbaugh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Burda","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, University of California, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Sofroniew","sequence":"additional","affiliation":[{"name":"Department of Neurobiology, University of California, Los Angeles, CA 90095"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda R.","family":"Voskuhl","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of California, Los Angeles, CA 90095;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2017,12,26]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nn.4043","article-title":"Diversity of astrocyte functions and phenotypes in neural circuits","volume":"18","author":"Khakh BS","year":"2015","unstructured":"BS Khakh, MV Sofroniew, Diversity of astrocyte functions and phenotypes in neural circuits. Nat Neurosci 18, 942\u2013952 (2015).","journal-title":"Nat Neurosci"},{"key":"e_1_3_4_2_2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1073\/pnas.1222897110","article-title":"Cell type-specific genes show striking and distinct patterns of spatial expression in the mouse brain","volume":"110","author":"Ko Y","year":"2013","unstructured":"Y Ko, , Cell type-specific genes show striking and distinct patterns of spatial expression in the mouse brain. Proc Natl Acad Sci USA 110, 3095\u20133100 (2013).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_3_2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/nn.3503","article-title":"Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain","volume":"16","author":"Vigan\u00f2 F","year":"2013","unstructured":"F Vigan\u00f2, W M\u00f6bius, M G\u00f6tz, L Dimou, Transplantation reveals regional differences in oligodendrocyte differentiation in the adult brain. Nat Neurosci 16, 1370\u20131372 (2013).","journal-title":"Nat Neurosci"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/jamaneurol.2016.0966","article-title":"Disability-specific atlases of gray matter loss in relapsing-remitting multiple sclerosis","volume":"73","author":"MacKenzie-Graham A","year":"2016","unstructured":"A MacKenzie-Graham, , Disability-specific atlases of gray matter loss in relapsing-remitting multiple sclerosis. JAMA Neurol 73, 944\u2013953 (2016).","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_5_2","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/jamaneurol.2016.1535","article-title":"Cortical volume loss and neurologic dysfunction in multiple sclerosis","volume":"73","author":"Racke MK","year":"2016","unstructured":"MK Racke, J Imitola, Cortical volume loss and neurologic dysfunction in multiple sclerosis. JAMA Neurol 73, 910\u2013912 (2016).","journal-title":"JAMA Neurol"},{"key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/glia.20057","article-title":"Laser microdissection reveals regional and cellular differences in GFAP mRNA upregulation following brain injury, axonal denervation, and amyloid plaque deposition","volume":"48","author":"Burbach GJ","year":"2004","unstructured":"GJ Burbach, D Dehn, D Del Turco, M Staufenbiel, T Deller, Laser microdissection reveals regional and cellular differences in GFAP mRNA upregulation following brain injury, axonal denervation, and amyloid plaque deposition. Glia 48, 76\u201384 (2004).","journal-title":"Glia"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneumeth.2004.03.022","article-title":"Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression","volume":"138","author":"Burbach GJ","year":"2004","unstructured":"GJ Burbach, D Dehn, B Nagel, D Del Turco, T Deller, Laser microdissection of immunolabeled astrocytes allows quantification of astrocytic gene expression. J Neurosci Methods 138, 141\u2013148 (2004).","journal-title":"J Neurosci Methods"},{"key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"aad8670","DOI":"10.1126\/science.aad8670","article-title":"Microglia development follows a stepwise program to regulate brain homeostasis","volume":"353","author":"Matcovitch-Natan O","year":"2016","unstructured":"O Matcovitch-Natan, , Microglia development follows a stepwise program to regulate brain homeostasis. Science 353, aad8670 (2016).","journal-title":"Science"},{"key":"e_1_3_4_9_2","doi-asserted-by":"crossref","first-page":"13939","DOI":"10.1073\/pnas.0907143106","article-title":"Cell-type-specific isolation of ribosome-associated mRNA from complex tissues","volume":"106","author":"Sanz E","year":"2009","unstructured":"E Sanz, , Cell-type-specific isolation of ribosome-associated mRNA from complex tissues. Proc Natl Acad Sci USA 106, 13939\u201313944 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.1103833108","article-title":"Neuroprotection mediated through estrogen receptor-alpha in astrocytes","volume":"108","author":"Spence RD","year":"2011","unstructured":"RD Spence, , Neuroprotection mediated through estrogen receptor-alpha in astrocytes. Proc Natl Acad Sci USA 108, 8867\u20138872 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_11_2","doi-asserted-by":"crossref","first-page":"11511","DOI":"10.1523\/JNEUROSCI.1514-09.2009","article-title":"Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS","volume":"29","author":"Voskuhl RR","year":"2009","unstructured":"RR Voskuhl, , Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29, 11511\u201311522 (2009).","journal-title":"J Neurosci"},{"key":"e_1_3_4_12_2","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.22443","article-title":"The astrocyte in multiple sclerosis revisited","volume":"61","author":"Brosnan CF","year":"2013","unstructured":"CF Brosnan, CS Raine, The astrocyte in multiple sclerosis revisited. Glia 61, 453\u2013465 (2013).","journal-title":"Glia"},{"key":"e_1_3_4_13_2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nature17623","article-title":"Astrocyte scar formation aids central nervous system axon regeneration","volume":"532","author":"Anderson MA","year":"2016","unstructured":"MA Anderson, , Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195\u2013200 (2016).","journal-title":"Nature"},{"key":"e_1_3_4_14_2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A","article-title":"Brain-immune connection: Immuno-regulatory properties of CNS-resident cells","volume":"29","author":"Becher B","year":"2000","unstructured":"B Becher, A Prat, JP Antel, Brain-immune connection: Immuno-regulatory properties of CNS-resident cells. Glia 29, 293\u2013304 (2000).","journal-title":"Glia"},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nrn3898","article-title":"Astrocyte barriers to neurotoxic inflammation","volume":"16","author":"Sofroniew MV","year":"2015","unstructured":"MV Sofroniew, Astrocyte barriers to neurotoxic inflammation. Nat Rev Neurosci 16, 249\u2013263 (2015).","journal-title":"Nat Rev Neurosci"},{"key":"e_1_3_4_16_2","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1073\/pnas.1307091111","article-title":"XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis","volume":"111","author":"Du S","year":"2014","unstructured":"S Du, , XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 111, 2806\u20132811 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_17_2","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neuroimage.2009.06.073","article-title":"Purkinje cell loss in experimental autoimmune encephalomyelitis","volume":"48","author":"MacKenzie-Graham A","year":"2009","unstructured":"A MacKenzie-Graham, , Purkinje cell loss in experimental autoimmune encephalomyelitis. Neuroimage 48, 637\u2013651 (2009).","journal-title":"Neuroimage"},{"key":"e_1_3_4_18_2","doi-asserted-by":"crossref","first-page":"e54666","DOI":"10.1371\/journal.pone.0054666","article-title":"Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis","volume":"8","author":"Nistic\u00f2 R","year":"2013","unstructured":"R Nistic\u00f2, , Inflammation subverts hippocampal synaptic plasticity in experimental multiple sclerosis. PLoS One 8, e54666 (2013).","journal-title":"PLoS One"},{"key":"e_1_3_4_19_2","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/brain\/awm219","article-title":"Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing\u2013Remitting experimental autoimmune encephalomyelitis","volume":"130","author":"Rasmussen S","year":"2007","unstructured":"S Rasmussen, , Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing\u2013Remitting experimental autoimmune encephalomyelitis. Brain 130, 2816\u20132829 (2007).","journal-title":"Brain"},{"key":"e_1_3_4_20_2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.neuroimage.2014.07.017","article-title":"Bringing CLARITY to gray matter atrophy","volume":"101","author":"Spence RD","year":"2014","unstructured":"RD Spence, , Bringing CLARITY to gray matter atrophy. Neuroimage 101, 625\u2013632 (2014).","journal-title":"Neuroimage"},{"key":"e_1_3_4_21_2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/labinvest.2010.6","article-title":"Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE","volume":"90","author":"Ziehn MO","year":"2010","unstructured":"MO Ziehn, AA Avedisian, S Tiwari-Woodruff, RR Voskuhl, Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE. Lab Invest 90, 774\u2013786 (2010).","journal-title":"Lab Invest"},{"key":"e_1_3_4_22_2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4049\/jimmunol.1401320","article-title":"CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression","volume":"194","author":"Clarkson BD","year":"2015","unstructured":"BD Clarkson, , CCR2-dependent dendritic cell accumulation in the central nervous system during early effector experimental autoimmune encephalomyelitis is essential for effector T cell restimulation in situ and disease progression. J Immunol 194, 531\u2013541 (2015).","journal-title":"J Immunol"},{"key":"e_1_3_4_23_2","doi-asserted-by":"crossref","first-page":"14965","DOI":"10.1523\/JNEUROSCI.3794-09.2009","article-title":"Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis","volume":"29","author":"Soulika AM","year":"2009","unstructured":"AM Soulika, , Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci 29, 14965\u201314979 (2009).","journal-title":"J Neurosci"},{"key":"e_1_3_4_24_2","doi-asserted-by":"crossref","first-page":"14813","DOI":"10.1073\/pnas.0703783104","article-title":"Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment","volume":"104","author":"Tiwari-Woodruff S","year":"2007","unstructured":"S Tiwari-Woodruff, LB Morales, R Lee, RR Voskuhl, Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc Natl Acad Sci USA 104, 14813\u201314818 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_3_4_25_2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbalip.2015.02.010","article-title":"Cholesterol in myelin biogenesis and hypomyelinating disorders","volume":"1851","author":"Saher G","year":"2015","unstructured":"G Saher, SK Stumpf, Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta 1851, 1083\u20131094 (2015).","journal-title":"Biochim Biophys Acta"},{"key":"e_1_3_4_26_2","doi-asserted-by":"crossref","first-page":"e0166195","DOI":"10.1371\/journal.pone.0166195","article-title":"Differential effects of apoE4 and activation of ABCA1 on brain and plasma lipoproteins","volume":"11","author":"Boehm-Cagan A","year":"2016","unstructured":"A Boehm-Cagan, , Differential effects of apoE4 and activation of ABCA1 on brain and plasma lipoproteins. PLoS One 11, e0166195 (2016).","journal-title":"PLoS One"},{"key":"e_1_3_4_27_2","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3233\/JAD-160467","article-title":"ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies","volume":"54","author":"Boehm-Cagan A","year":"2016","unstructured":"A Boehm-Cagan, , ABCA1 agonist reverses the ApoE4-driven cognitive and brain pathologies. J Alzheimers Dis 54, 1219\u20131233 (2016).","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_4_28_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/hipo.20548","article-title":"Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus","volume":"19","author":"Fester L","year":"2009","unstructured":"L Fester, , Cholesterol-promoted synaptogenesis requires the conversion of cholesterol to estradiol in the hippocampus. Hippocampus 19, 692\u2013705 (2009).","journal-title":"Hippocampus"},{"key":"e_1_3_4_29_2","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.294.5545.1354","article-title":"CNS synaptogenesis promoted by glia-derived cholesterol","volume":"294","author":"Mauch DH","year":"2001","unstructured":"DH Mauch, , CNS synaptogenesis promoted by glia-derived cholesterol. Science 294, 1354\u20131357 (2001).","journal-title":"Science"},{"key":"e_1_3_4_30_2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nn1426","article-title":"High cholesterol level is essential for myelin membrane growth","volume":"8","author":"Saher G","year":"2005","unstructured":"G Saher, , High cholesterol level is essential for myelin membrane growth. Nat Neurosci 8, 468\u2013475 (2005).","journal-title":"Nat Neurosci"},{"key":"e_1_3_4_31_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.neuint.2009.09.009","article-title":"Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels","volume":"56","author":"Giatti S","year":"2010","unstructured":"S Giatti, , Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels. Neurochem Int 56, 118\u2013127 (2010).","journal-title":"Neurochem Int"},{"key":"e_1_3_4_32_2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00018-007-7403-5","article-title":"Neuroactive steroids: State of the art and new perspectives","volume":"65","author":"Melcangi RC","year":"2008","unstructured":"RC Melcangi, LM Garcia-Segura, AG Mensah-Nyagan, Neuroactive steroids: State of the art and new perspectives. Cell Mol Life Sci 65, 777\u2013797 (2008).","journal-title":"Cell Mol Life Sci"},{"key":"e_1_3_4_33_2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1365-2826.2001.00647.x","article-title":"Rapid upregulation of aromatase mRNA and protein following neural injury in the zebra finch (Taeniopygia guttata)","volume":"13","author":"Peterson RS","year":"2001","unstructured":"RS Peterson, CJ Saldanha, BA Schlinger, Rapid upregulation of aromatase mRNA and protein following neural injury in the zebra finch (Taeniopygia guttata). J Neuroendocrinol 13, 317\u2013323 (2001).","journal-title":"J Neuroendocrinol"},{"key":"e_1_3_4_34_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2011.04.010","article-title":"Neurosteroid and GABA-A receptor alterations in Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis","volume":"191","author":"Luchetti S","year":"2011","unstructured":"S Luchetti, I Huitinga, DF Swaab, Neurosteroid and GABA-A receptor alterations in Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis. Neuroscience 191, 6\u201321 (2011).","journal-title":"Neuroscience"},{"key":"e_1_3_4_35_2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/NEN.0000000000000037","article-title":"Gender differences in multiple sclerosis: Induction of estrogen signaling in male and progesterone signaling in female lesions","volume":"73","author":"Luchetti S","year":"2014","unstructured":"S Luchetti, , Gender differences in multiple sclerosis: Induction of estrogen signaling in male and progesterone signaling in female lesions. J Neuropathol Exp Neurol 73, 123\u2013135 (2014).","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_3_4_36_2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/brain\/aws284","article-title":"The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination","volume":"136","author":"Hussain R","year":"2013","unstructured":"R Hussain, , The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination. Brain 136, 132\u2013146 (2013).","journal-title":"Brain"},{"key":"e_1_3_4_37_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yfrne.2011.12.001","article-title":"Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration","volume":"33","author":"Spence RD","year":"2012","unstructured":"RD Spence, RR Voskuhl, Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration. Front Neuroendocrinol 33, 105\u2013115 (2012).","journal-title":"Front Neuroendocrinol"},{"key":"e_1_3_4_38_2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrneurol.2012.43","article-title":"Sex-related factors in multiple sclerosis susceptibility and progression","volume":"8","author":"Voskuhl RR","year":"2012","unstructured":"RR Voskuhl, SM Gold, Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 8, 255\u2013263 (2012).","journal-title":"Nat Rev Neurol"},{"key":"e_1_3_4_39_2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.nicl.2014.03.001","article-title":"Neuroprotective effects of testosterone treatment in men with multiple sclerosis","volume":"4","author":"Kurth F","year":"2014","unstructured":"F Kurth, , Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 4, 454\u2013460 (2014).","journal-title":"Neuroimage Clin"},{"key":"e_1_3_4_40_2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archneur.64.5.683","article-title":"Testosterone treatment in multiple sclerosis: A pilot study","volume":"64","author":"Sicotte NL","year":"2007","unstructured":"NL Sicotte, , Testosterone treatment in multiple sclerosis: A pilot study. Arch Neurol 64, 683\u2013688 (2007).","journal-title":"Arch Neurol"},{"key":"e_1_3_4_41_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.10301","article-title":"Treatment of multiple sclerosis with the pregnancy hormone estriol","volume":"52","author":"Sicotte NL","year":"2002","unstructured":"NL Sicotte, , Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 52, 421\u2013428 (2002).","journal-title":"Ann Neurol"},{"key":"e_1_3_4_42_2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S1474-4422(16)00129-0","article-title":"Why use sex hormones in relapsing-remitting multiple sclerosis?\u2013Authors\u2019 reply","volume":"15","author":"Voskuhl R","year":"2016","unstructured":"R Voskuhl, H Wang, RM Elashoff, Why use sex hormones in relapsing-remitting multiple sclerosis?\u2013Authors\u2019 reply. Lancet Neurol 15, 790\u2013791 (2016).","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_43_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1474-4422(15)00322-1","article-title":"Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial","volume":"15","author":"Voskuhl RR","year":"2016","unstructured":"RR Voskuhl, , Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15, 35\u201346 (2016).","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_44_2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1474-4422(04)00964-0","article-title":"Biological markers in CSF and blood for axonal degeneration in multiple sclerosis","volume":"4","author":"Teunissen CE","year":"2005","unstructured":"CE Teunissen, C Dijkstra, C Polman, Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. Lancet Neurol 4, 32\u201341 (2005).","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_45_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1177\/1352458513499421","article-title":"Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis","volume":"20","author":"van de Kraats C","year":"2014","unstructured":"C van de Kraats, , Oxysterols and cholesterol precursors correlate to magnetic resonance imaging measures of neurodegeneration in multiple sclerosis. Mult Scler 20, 412\u2013417 (2014).","journal-title":"Mult Scler"},{"key":"e_1_3_4_46_2","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): A randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway J","year":"2014","unstructured":"J Chataway, , Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): A randomised, placebo-controlled, phase 2 trial. Lancet 383, 2213\u20132221 (2014).","journal-title":"Lancet"},{"key":"e_1_3_4_47_2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(14)61621-4","article-title":"Simvastatin in patients with progressive multiple sclerosis","volume":"384","author":"Giovannoni G","year":"2014","unstructured":"G Giovannoni, D Baker, K Schmierer, Simvastatin in patients with progressive multiple sclerosis. Lancet 384, 952 (2014).","journal-title":"Lancet"},{"key":"e_1_3_4_48_2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef S","year":"2002","unstructured":"S Youssef, , The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78\u201384 (2002).","journal-title":"Nature"},{"key":"e_1_3_4_49_2","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrneurol.2011.61","article-title":"Risk factors for and management of cognitive dysfunction in multiple sclerosis","volume":"7","author":"Benedict RH","year":"2011","unstructured":"RH Benedict, R Zivadinov, Risk factors for and management of cognitive dysfunction in multiple sclerosis. Nat Rev Neurol 7, 332\u2013342 (2011).","journal-title":"Nat Rev Neurol"},{"key":"e_1_3_4_50_2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1212\/01.wnl.0000264004.62612.44","article-title":"APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis","volume":"70","author":"Shi J","year":"2008","unstructured":"J Shi, CB Zhao, TL Vollmer, TM Tyry, SM Kuniyoshi, APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis. Neurology 70, 185\u2013190 (2008).","journal-title":"Neurology"},{"key":"e_1_3_4_51_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-130623","article-title":"Cognitive impairment in neurological diseases: Lessons from apolipoprotein E","volume":"38","author":"Shi J","year":"2014","unstructured":"J Shi, P Han, SM Kuniyoshi, Cognitive impairment in neurological diseases: Lessons from apolipoprotein E. J Alzheimers Dis 38, 1\u20139 (2014).","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_4_52_2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti ND","year":"2008","unstructured":"ND Chiaravalloti, J DeLuca, Cognitive impairment in multiple sclerosis. Lancet Neurol 7, 1139\u20131151 (2008).","journal-title":"Lancet Neurol"},{"key":"e_1_3_4_53_2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.nbd.2012.12.009","article-title":"Effects of central and peripheral inflammation on hippocampal synaptic plasticity","volume":"52","author":"Di Filippo M","year":"2013","unstructured":"M Di Filippo, , Effects of central and peripheral inflammation on hippocampal synaptic plasticity. Neurobiol Dis 52, 229\u2013236 (2013).","journal-title":"Neurobiol Dis"},{"key":"e_1_3_4_54_2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/labinvest.2012.76","article-title":"Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease","volume":"92","author":"Ziehn MO","year":"2012","unstructured":"MO Ziehn, AA Avedisian, SM Dervin, TJ O\u2019Dell, RR Voskuhl, Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease. Lab Invest 92, 1234\u20131245 (2012).","journal-title":"Lab Invest"},{"key":"e_1_3_4_55_2","doi-asserted-by":"crossref","first-page":"12312","DOI":"10.1523\/JNEUROSCI.2796-12.2012","article-title":"Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease","volume":"32","author":"Ziehn MO","year":"2012","unstructured":"MO Ziehn, , Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease. J Neurosci 32, 12312\u201312324 (2012).","journal-title":"J Neurosci"},{"key":"e_1_3_4_56_2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/bpa.12220","article-title":"Cognitive impairment in multiple sclerosis: Clinical, radiologic and pathologic insights","volume":"25","author":"DeLuca GC","year":"2015","unstructured":"GC DeLuca, RL Yates, H Beale, SA Morrow, Cognitive impairment in multiple sclerosis: Clinical, radiologic and pathologic insights. Brain Pathol 25, 79\u201398 (2015).","journal-title":"Brain Pathol"},{"key":"e_1_3_4_57_2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.mri.2013.12.012","article-title":"Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis","volume":"32","author":"Koenig KA","year":"2014","unstructured":"KA Koenig, , Hippocampal volume is related to cognitive decline and fornicial diffusion measures in multiple sclerosis. Magn Reson Imaging 32, 354\u2013358 (2014).","journal-title":"Magn Reson Imaging"},{"key":"e_1_3_4_58_2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1093\/brain\/awn030","article-title":"Regional hippocampal atrophy in multiple sclerosis","volume":"131","author":"Sicotte NL","year":"2008","unstructured":"NL Sicotte, , Regional hippocampal atrophy in multiple sclerosis. Brain 131, 1134\u20131141 (2008).","journal-title":"Brain"},{"key":"e_1_3_4_59_2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1191\/1352458503ms917oa","article-title":"Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration","volume":"9","author":"B\u00f8 L","year":"2003","unstructured":"L B\u00f8, CA Vedeler, H Nyland, BD Trapp, SJ M\u00f8rk, Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9, 323\u2013331 (2003).","journal-title":"Mult Scler"},{"key":"e_1_3_4_60_2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/nyas.12841","article-title":"Pathological differences between white and grey matter multiple sclerosis lesions","volume":"1351","author":"Prins M","year":"2015","unstructured":"M Prins, , Pathological differences between white and grey matter multiple sclerosis lesions. Ann N Y Acad Sci 1351, 99\u2013113 (2015).","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_3_4_61_2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms regulating regional localization of inflammation during CNS autoimmunity","volume":"248","author":"Pierson E","year":"2012","unstructured":"E Pierson, SB Simmons, L Castelli, JM Goverman, Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol Rev 248, 205\u2013215 (2012).","journal-title":"Immunol Rev"},{"key":"e_1_3_4_62_2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.4049\/jimmunol.1400825","article-title":"Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis","volume":"193","author":"Stoolman JS","year":"2014","unstructured":"JS Stoolman, PC Duncker, AK Huber, BM Segal, Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis. J Immunol 193, 564\u2013570 (2014).","journal-title":"J Immunol"},{"key":"e_1_3_4_63_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nm1715","article-title":"Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells","volume":"14","author":"Stromnes IM","year":"2008","unstructured":"IM Stromnes, LM Cerretti, D Liggitt, RA Harris, JM Goverman, Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells. Nat Med 14, 337\u2013342 (2008).","journal-title":"Nat Med"},{"key":"e_1_3_4_64_2","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1523\/JNEUROSCI.5273-08.2009","article-title":"Lipocalin-2 is an autocrine mediator of reactive astrocytosis","volume":"29","author":"Lee S","year":"2009","unstructured":"S Lee, , Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 29, 234\u2013249 (2009).","journal-title":"J Neurosci"},{"key":"e_1_3_4_65_2","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1167\/iovs.15-16851","article-title":"Pathological Involvement of astrocyte-derived lipocalin-2 in the demyelinating optic neuritis","volume":"56","author":"Chun BY","year":"2015","unstructured":"BY Chun, , Pathological Involvement of astrocyte-derived lipocalin-2 in the demyelinating optic neuritis. Invest Ophthalmol Vis Sci 56, 3691\u20133698 (2015).","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_4_66_2","doi-asserted-by":"crossref","first-page":"43855","DOI":"10.1074\/jbc.M111.299248","article-title":"Lipocalin-2 is a chemokine inducer in the central nervous system: Role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration","volume":"286","author":"Lee S","year":"2011","unstructured":"S Lee, , Lipocalin-2 is a chemokine inducer in the central nervous system: Role of chemokine ligand 10 (CXCL10) in lipocalin-2-induced cell migration. J Biol Chem 286, 43855\u201343870 (2011).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_67_2","doi-asserted-by":"crossref","first-page":"16773","DOI":"10.1074\/jbc.M113.542282","article-title":"Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: The pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues","volume":"289","author":"Nam Y","year":"2014","unstructured":"Y Nam, , Lipocalin-2 protein deficiency ameliorates experimental autoimmune encephalomyelitis: The pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues. J Biol Chem 289, 16773\u201316789 (2014).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_68_2","doi-asserted-by":"crossref","first-page":"24138","DOI":"10.1074\/jbc.M604597200","article-title":"Identification of common transcriptional regulatory elements in interleukin-17 target genes","volume":"281","author":"Shen F","year":"2006","unstructured":"F Shen, Z Hu, J Goswami, SL Gaffen, Identification of common transcriptional regulatory elements in interleukin-17 target genes. J Biol Chem 281, 24138\u201324148 (2006).","journal-title":"J Biol Chem"},{"key":"e_1_3_4_69_2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molmet.2013.04.003","article-title":"STAT1, NF-\u03baB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes","volume":"2","author":"Zhao P","year":"2013","unstructured":"P Zhao, JM Stephens, STAT1, NF-\u03baB and ERKs play a role in the induction of lipocalin-2 expression in adipocytes. Mol Metab 2, 161\u2013170 (2013).","journal-title":"Mol Metab"},{"key":"e_1_3_4_70_2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1194\/jlr.M003665","article-title":"A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice","volume":"51","author":"Bielicki JK","year":"2010","unstructured":"JK Bielicki, , A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. J Lipid Res 51, 1496\u20131503 (2010).","journal-title":"J Lipid Res"},{"key":"e_1_3_4_71_2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2016.09.017","article-title":"Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis","volume":"304","author":"Itoh N","year":"2017","unstructured":"N Itoh, , Bedside to bench to bedside research: Estrogen receptor beta ligand as a candidate neuroprotective treatment for multiple sclerosis. J Neuroimmunol 304, 63\u201371 (2017).","journal-title":"J Neuroimmunol"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1716032115","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1716032115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T14:00:43Z","timestamp":1654610443000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1716032115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,26]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,9]]}},"alternative-id":["10.1073\/pnas.1716032115"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1716032115","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,26]]},"assertion":[{"value":"2017-12-26","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}